The high incidence of EB virus infections (and possibly of other viruses) in patients with African lymphoma and, to a lesser extent, in patients with lymphosarcoma in the temperate zones, is thought to be due to its being a passenger virus which persists in the human body and, since it is lymphotropic, presents an opportunistic infection of proliferating lymphoid cells. The thesis is put forward that by entering the cell nucleus, the virus renders malignant lymphoid cells more vulnerable to cytotoxic drugs. Hence a deliberate policy of EB virus inoculation before starting chemotherapy might achieve a more rapid response and longer remissions in indigenous lymphomas of the temperate zones, and might possibly render drug-resistant cases once more drug-sensitive.
Notes
Cites: Cancer. 1966 Aug;19(8):1131-75912327
Cites: Br Med J. 1964 May 9;1(5392):1212-314120827
Cites: Cancer. 1967 May;20(5):756-96024288
Cites: Cancer. 1967 May;20(5):760-775337395
Cites: Cancer. 1968 Apr;21(4):553-74296158
Cites: Cancer. 1968 Apr;21(4):563-745238815
Cites: Cancer. 1968 Apr;21(4):580-64868472
Cites: Cancer. 1968 Apr;21(4):595-95238817
Cites: Cancer. 1968 Dec;22(6):1283-914884061
Cites: Cancer. 1969 Feb;23(2):300-54303775
Cites: Cancer. 1969 Apr;23(4):990-74975669
Cites: Cancer. 1969 Jun;23(6):1259-725771062
Cites: Cancer. 1970 Mar;25(3):505-95416823
Cites: Cancer. 1970 Mar;25(3):734-94984654
Cites: Indian J Cancer. 1970 Jun;7(2):140-25507060